Metraipolis › archive › dc_3c8d541af697

A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for Cytomegalovirus (CMV) Prophylaxis in High-Risk… — Europe PMC PMID:41018408

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41018408
DOI
10.7759/cureus.91110
License (as archived)
solo-consultazione
Archived
2026-11-10T07:47:13.035Z
SHA-256 of the archived text
96282b5109a1458ee76ae1ea5eeff620ecace0b8e5c976de74d693dfb401e759
Stable URL of this page
https://metraipolis.com/documento/dc_3c8d541af697

How to cite

A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for Cytomegalovirus (CMV) Prophylaxis in High-Risk… — Europe PMC PMID:41018408 — Europe PMC (en), https://europepmc.org/article/MED/41018408 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3c8d541af697 (Metraipolis archive dc_3c8d541af697, sha256 96282b5109a1458ee76ae1ea5eeff620ecace0b8e5c976de74d693dfb401e759)
BibTeX
@misc{dc3c8d541af697,
  title = {A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for Cytomegalovirus (CMV) Prophylaxis in High-Risk… — Europe PMC PMID:41018408},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41018408},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3c8d541af697; sha256 96282b5109a1458ee76ae1ea5eeff620ecace0b8e5c976de74d693dfb401e759},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41018408. Agents can read the archived copy with the MCP tool read_document.